40 results on '"Heusschen, Roy"'
Search Results
2. Figure S1 from Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion
3. Supplementary Data from Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion
4. Supplementary Table 1 from Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion
5. Data from Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion
6. Different angioregulatory activity of monovalent galectin-9 isoforms
7. Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts
8. Galectin expression in cancer diagnosis and prognosis: A systematic review
9. Galectin-9 in tumor biology: A jack of multiple trades
10. MicroRNAs in the tumor endothelium: Novel controls on the angioregulatory switchboard
11. Chemokines modulate glycan binding and immunoregulatory activity of galectins
12. Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease
13. Altered chondrocyte differentiation, matrix mineralization and MEK-Erk1/2 signaling in an INPPL1 catalytic knock-out mouse model of opsismodysplasia
14. Inhibition of multiple myeloma exosomes prevents bone loss and reduces tumor growth
15. Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts
16. Abstract 2120: Inhibition of multiple myeloma exosomes prevents bone loss and reduces tumor growth
17. Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma
18. Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion
19. The changing landscape of smoldering multiple myeloma: a European perspective
20. Molecular mechanisms, current management and next generation therapy in myeloma bone disease
21. Maternal Embryonic Leucine Zipper Kinase (MELK) Drives a High-Risk Gene Network and Represents an Attractive Novel Drug Target in Multiple Myeloma
22. Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma
23. Galectin-1 is involved in osteoclast biology
24. The SRC kinase inhibitor saracatinib limits the development of osteolytic bone disease in multiple myeloma
25. SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
26. The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective
27. The Src Inhibitor AZD0530 Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
28. Profiling Lgals9 Splice Variant Expression at the Fetal-Maternal Interface: Implications in Normal and Pathological Human Pregnancy
29. Molecular mechanisms, current management and next generation therapy in myeloma bone disease.
30. Preclinical Evaluation of the First in Class BMI1 Inhibitor PTC-028 Confirms Potent Efficacy to Target BMI1-Addiction in Multiple Myeloma
31. Establishment of a Murine Graft-versus-Myeloma Model Using Allogeneic Stem Cell Transplantation
32. Galectin Expression Profiling Identifies Galectin-1 and Galectin-9Δ5 as Prognostic Factors in Stage I/II Non-Small Cell Lung Cancer
33. Endothelial LGALS9 splice variant expression in endothelial cell biology and angiogenesis
34. Abstract 38: Galectin-9D5 is a prognostic marker in early stage non-small cell lung cancer.
35. Abstract 3490: Identification and characterization of novel galectin-9 splice variants in endothelial cells
36. Maternal Embryonic Leucine Zipper Kinase Inhibitor OTSSP167 Inhibits Osteoclast Activity and Restores Osteoblast Activity in a Murine Model of Multiple Myeloma Bone Disease
37. Profiling Lgals9 Splice Variant Expression at the Fetal-Maternal Interface: Implications in Normal and Pathological Human Pregnancy1
38. Profiling Lgals9Splice Variant Expression at the Fetal-Maternal Interface: Implications in Normal and Pathological Human Pregnancy1
39. Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma.
40. Profiling Lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.